IL-6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID-19 patients.

Hossein Mostafa ElbadawyAmin KhattabDina S El-AgamyHeba M EltahirAisha AlhaddadFahad Dakilallah AljohaniTarraji Mohammed AlmuzainiMekky M AbouziedAhmed Aldhafiri

Published in: Journal of clinical laboratory analysis (2023)

Having the most significant correlations, IL-6 high levels in mechanically ventilated patients were shown to affect laboratory results, and, therefore, is suggested as a severity biomarker of COVID-19.

Keyphrases

sars cov
end stage renal disease
chronic kidney disease
coronavirus disease
ejection fraction
newly diagnosed
oxidative stress
intensive care unit
prognostic factors
peritoneal dialysis
patient reported outcomes
acute respiratory distress syndrome